Effects of Salvia miltiorrhiza extract on lung adenocarcinoma

Huixiang Tian1,2, Yueqin Li3, Jie Mei2

  • 1Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.

Insights

Tanshinone I from Salvia miltiorrhiza inhibits lung adenocarcinoma cell proliferation. This study identified key gene expression changes and signaling pathways, including PI3K-Akt, and showed salvianolate suppressed tumor growth in vivo.

Area of Science:

  • Oncology
  • Pharmacology
  • Genomics

Background:

  • Lung adenocarcinoma is a prevalent non-small cell lung carcinoma subtype.
  • Tanshinone I, a Salvia miltiorrhiza component, shows potential in inhibiting lung adenocarcinoma cell proliferation.
  • Gene expression and signaling pathway alterations following Tanshinone I treatment remain underexplored.

Purpose of the Study:

  • To investigate gene expression and signaling pathway changes in lung adenocarcinoma cells treated with Tanshinone I.
  • To identify potential therapeutic targets for lung adenocarcinoma.
  • To evaluate the in vivo efficacy of salvianolate in suppressing lung adenocarcinoma growth.

Main Methods:

  • Gene Expression Omnibus (GEO) dataset GSE9315 was analyzed to identify differentially expressed genes (DEGs) and enriched pathways.
  • Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis was performed.
  • Nude mouse xenograft models were used to assess the in vivo effects of salvianolate.

Main Results:

  • Tanshinone I treatment resulted in 28 DEGs in low-dose and 102 DEGs in medium-dose groups, enriched in pathways like 'positive regulation of T-helper cell differentiation' and 'MAPK cascade'.
  • The PI3K-Akt signaling pathway was significantly enriched in both dosage groups.
  • Salvianolate suppressed lung adenocarcinoma tumor growth in vivo and downregulated ATP7A and ATP7B expression.

Conclusions:

  • Tanshinone I and salvianolate demonstrate therapeutic potential for lung adenocarcinoma.
  • Nine overlapping DEGs were identified as potential therapeutic targets.
  • Salvia miltiorrhiza extract warrants further investigation for clinical application in treating lung adenocarcinomas.

Related Concept Videos